Number of the records: 1
Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine
SYS r032318 LBL ^^^^^naa^^22^^^^^^^^450^ 005 20130617161819.7 100 $a 20050322a2005 m y0sloc0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine $f C. Lakshmi ... [et al.] 215 $c Obr., tab. 320 $a Res. angl. 320 $a Bibliogr. odkazy 463 -1
$1 001 sllk_un_cat*sg000148_2005_005_001 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 52, no. 1 (2005), p. 68-73 $1 210 $a Bratislava $c Veda 541 1-
$a Redukcia hematotoxicity a zvýšenie protinádorovej účinnosti cyklofosfamidu s dopamínom 606 1-
$a cyklofosfamid $x aplikácia a dávkovanie $x farmakokinetika $x použitie terapeutické $2 mesh $3 sllk_un_auth*d003520 $9 . 606 1-
$a dopamín $x aplikácia a dávkovanie $x farmakokinetika $x použitie terapeutické $2 mesh $3 sllk_un_auth*d004298 $9 . 606 1-
$3 sllk_un_auth*d006460 $a proteíny hemolyzínové $x analýza $x použitie diagnostické $9 . $2 mesh 606 2-
$a nádory $x diagnostika $2 mesh $3 sllk_un_auth*d009369 $9 . 606 2-
$3 sllk_un_auth*d007951 $a leukémia myeloidná $9 . $2 mesh 675 $a 616.155-092-085 $v 2. $z slo 701 -1
$a Lakshmi $b C. $3 sllk_un_auth*p0040291 $4 070 $p Esperimental hematology unit, Chittaranjan national cancer institute, Kalkata, India 701 -1
$a Deb $b C. $3 sllk_un_auth*p0040292 $4 070 $p Esperimental hematology unit, Chittaranjan national cancer institute, Kalkata, India 701 -1
$a Ray $b C. $3 sllk_un_auth*p0040293 $4 070 $p Esperimental hematology unit, Chittaranjan national cancer institute, Kalkata, India 701 -1
$a Ray $b M.R. $3 sllk_un_auth*p0040294 $4 070 $p Esperimental hematology unit, Chittaranjan national cancer institute, Kalkata, India 801 -0
$a SK $b BA006 $c 20050322 $g AACR2
Number of the records: 1